KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MCRB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Seres Therapeutics stock price on Thursday moving between $0.700 and $0.83
(Updated on Apr 25, 2024)

Sell candidate since Apr 24, 2024 Gain 1.81% PDF

The Seres Therapeutics stock price gained 1.81% on the last trading day (Thursday, 25th Apr 2024), rising from $0.730 to $0.743. During the last trading day the stock fluctuated 18.39% from a day low at $0.700 to a day high of $0.83. The price has fallen in 6 of the last 10 days but is still up by 8.87% over the past 2 weeks. Volume fell on the last day by -2 million shares and in total, 3 million shares were bought and sold for approximately $2.55 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $0.740, a level that may pose a second chance to hit a runner. According to fan-theory $0.96 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MCRB Signals & Forecast

Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Seres Therapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.745. On a fall, the stock will find some support from the short-term average at $0.661. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, April 23, 2024, and so far it has fallen -2.28%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Seres Therapeutics stock

Seres Therapeutics finds support from accumulated volume at $0.730 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.129 between high and low, or 18.39%. For the last week, the stock has had daily average volatility of 16.07%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MCRB) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Seres Therapeutics to open at $0.757, and during the day (based on 14 day Average True Range), to move between $0.669 and $0.82, which gives a possible trading interval of +/-$0.0736 (+/-9.91%) up or down from last closing price. If Seres Therapeutics takes out the full calculated possible swing range there will be an estimated 19.81% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.730 (1.78%) than the resistance at $0.760 (2.33%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Seres Therapeutics stock A Buy?

Seres Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.434 Sell Candidate Unchanged

Predicted Opening Price for Seres Therapeutics of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$0.757 ( 1.97%) $0.743

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MCRB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.89 19.31 %
R2 0.84 12.68 %
R1 0.81 8.59 %
Current price: 0.743
Support S1 0.708 -4.66 %
S2 0.678 -8.75 %
S3 0.629 -15.38 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.86 15.79 %
R2 0.773 4.08 %
R1 0.760 2.33 %
Current price 0.743
Support S1 0.730 -1.78%
S2 0.726 -2.30%
S3 0.689 -7.18%

FAQ

What is the symbol for Seres Therapeutics Stock and on which exchange is it traded?
The symbol for Seres Therapeutics is MCRB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Seres Therapeutics Stock?
Seres Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Seres Therapeutics Stock?
Seres Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Seres Therapeutics Stock.

What's the current price of Seres Therapeutics Stock?
As of the end of day on the Apr 25, 2024, the price of an Seres Therapeutics (MCRB) share was $0.743.

What is the 52-week high and low for Seres Therapeutics Stock?
The 52-week high for Seres Therapeutics Stock is $6.65 and the 52-week low is $0.540.

What is the market capitalization of Seres Therapeutics Stock?
As of the Apr 25, 2024, the market capitalization of Seres Therapeutics is 112.154M.

When is the next earnings date for Seres Therapeutics?
The upcoming earnings date for Seres Therapeutics is May 14, 2024.
Click to get the best stock tips daily for free!

About Seres Therapeutics

Seres Therapeutics Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment of clostridium difficile infection (CDI). It is also developing SER-155, a cultivated bacteri... MCRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT